Randomized Phase II Trial of B-Lymphocyte Purging of Autologous Peripheral Blood Progenitor Cells in Patients With B-Cell Non-Hodgkin's Lymphoma: in Vivo Purging With Rituximab Versus Ex-Vivo Purging With Clinamacs CD34+ Cell Enrichment Device
Phase of Trial: Phase II
Latest Information Update: 16 Mar 2010
At a glance
- Drugs Rituximab (Primary) ; Carmustine; Cisplatin; Cyclophosphamide; Etoposide; Filgrastim
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 16 Mar 2010 Actual patient number (37) added as reported by ClinicalTrials.gov record.
- 16 Mar 2010 Actual end date (1 Mar 2009) added as reported by ClinicalTrials.gov record.